Rodrigo Bueno de Oliveira
Overview
Explore the profile of Rodrigo Bueno de Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelepenko L, Louca M, Fausto T, Bucharles S, Custodio M, Lucca Junior L, et al.
J Bras Nefrol
. 2025 Feb;
47(2):e20240158.
PMID: 39998901
Introduction: Chronic kidney disease (CKD) may lead to secondary hyperparathyroidism (SHP) and its treatment is based on the control of hyperphosphatemia, hypocalcemia, and serum parathormone hormone levels (PTH) levels. Despite...
2.
de Oliveira M, Bufarah M, Oliveira R, de Goes C, Balbi A
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594269
Background And Aims: The gold standard method for measuring resting energy expenditure (REE) is indirect calorimetry (IC) using an expensive device that requires specialized training. To overcome the limitations of...
3.
Oliveira R, Pelepenko L, de Oliveira M, Kamel S, Louvet L, Mazon T
Kidney Int
. 2024 Sep;
106(4):757-758.
PMID: 39304275
No abstract available.
4.
Lima A, Marques A, Oliveira R
J Bras Nefrol
. 2024 Sep;
46(3):e20240083.
PMID: 39241115
No abstract available.
5.
Barreto J, Martins M, Borges C, Vitte S, Nadruz Junior W, Oliveira R, et al.
J Bras Nefrol
. 2024 Aug;
46(4):e20240047.
PMID: 39186633
The accumulation of advanced glycation end-products (AGEs) elicits morphofunctional kidney impairment. AGEs levels can be noninvasively estimated by skin autofluorescence (SAF). We explored whether high SAF predicts kidney outcomes in...
6.
Louca M, Mendes A, Oliveira R
J Bras Nefrol
. 2024 Jun;
46(4):e20230207.
PMID: 38913332
No abstract available.
7.
Oliveira R, Pelepenko L, Masaro D, Lustosa G, de Oliveira M, Roza N, et al.
Kidney Int
. 2024 Jun;
106(3):400-407.
PMID: 38901606
Microplastics (MPs) and nanoplastics are small synthetic organic polymer particles (<5 mm and <1 μm, respectively) that originate directly from plastic compounds or result from the degradation of plastic. These...
8.
Oliveira R, Carvalho A, Jorgetti V
J Bras Nefrol
. 2024 May;
46(3):e20240023.
PMID: 38748946
In the last few years, evidence from the Brazilian Registry of Bone Biopsy (REBRABO) has pointed out a high incidence of aluminum (Al) accumulation in the bones of patients with...
9.
de Godoy H, Faria A, Roza N, Bach-Toledo L, Simabuco F, Scharlack N, et al.
ACS Infect Dis
. 2024 May;
10(6):1949-1957.
PMID: 38741263
is an important pathogen that causes nosocomial infections, resulting in unacceptable morbidity and mortality rates. In this work, we proposed the construction of a nanostructured ZnO-based electrochemical immunosensor for qualitative...
10.
Carbonara C, Barreto J, Roza N, Quadros K, Dos Reis L, Carvalho A, et al.
J Bras Nefrol
. 2023 Nov;
46(2):e20230119.
PMID: 37947359
Introduction: Renal osteodystrophy (ROD) refers to a group of bone morphological patterns that derive from distinct pathophysiological mechanisms. Whether the ROD subtypes influence long-term outcomes is unknown. Our objective was...